Showing results (31-40 of 224) with videos related to
Sort By:
Pageof 23
Journal of Medical Economics|April 19, 2021
Conversion from pegfilgrastim with on-body injector to pegfilgrastim-jmdb: cost-efficiency analysis and budget-neutral expanded access to prophylaxis and treatmentAli McBride, Karen MacDonald, Adolfo Fuentes-Alburo, et al.Journal of Medical Economics|May 18, 2021
Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancerAli McBride, Karen MacDonald, Adolfo Fuentes-Alburo, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2017
"Real-life" Effectiveness Studies of Omalizumab in Adult Patients with Severe Allergic Asthma: Meta-analysisAbdulaziz Alhossan, Christopher S Lee, Karen MacDonald, et al.International Journal of Clinical Pharmacy|December 3, 2013
A method for calculating adherence to polypharmacy from dispensing data recordsIsabelle Arnet, Ivo Abraham, Markus Messerli, et al.Patient Preference and Adherence|November 10, 2017
Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort studyAndrea Zimmer, Michael Coslovsky, Ivo Abraham, et al.Journal of the Advanced Practitioner in Oncology|February 19, 2021
Perceptions of Health-Care Workers of the Cost and Safety of Oral Oncolytic Agents for Patients: A SurveyMadeline Tompkinson, Kelly Fine, Dean Gruber, et al.Expert Opinion on Drug Safety|January 31, 2025
Infectious complications associated with immune and targeted anti-cancer therapies: a retrospective study of the FDA adverse events reporting system (FAERS)Yazed S Alsowaida, Ahmed Alsolami, Thamer A Almangour, et al.Journal of Medical Economics|October 3, 2024
Budget impact analysis of pembrolizumab versus the novel PD-1 inhibitor toripalimab in locally advanced or metastatic nonsquamous non-small cell lung cancerIvo Abraham, Matthias Calamia, Nimer Alkhatib, et al.Psycho-Oncology|February 5, 2020
Systematic review of longitudinal studies on chemotherapy-associated subjective cognitive impairment in cancer patientsHee-Ju Kim, Sun-Ok Jung, Hyang Kim, et al.Future Oncology (London, England)|August 23, 2014
Cost savings from anemia management with biosimilar epoetin alfa and increased access to targeted antineoplastic treatment: a simulation for the EU G5 countriesIvo Abraham, Lucy Han, Diana Sun, et al.Pageof 23